Shifamed LLC, a privately held medical device incubator, announced that Apama Medical, Inc., a Shifamed Portfolio Company, was acquired by Boston Scientific Corporation (NYSE: BSX) for $175 million in cash up-front and a maximum of $125 million in contingent payments over the period of 2018-2020, based on achievements of clinical and regulatory milestones.
Boston Scientific Corporation today announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF).
NuVera Medical, Inc., a portfolio company of Shifamed, LLC., announced today it has raised $11M in Series A financing. The financing, which closed on June 28, 2017, was led by The Capital Partnership with participation from GE Ventures, Lilly Asia Ventures, and Cormorant Asset Management.
Atia Vision, a privately held medical device company focused on developing an accommodating intraocular lens to address the unmet clinical needs in the intraocular lens replacement market, today announced it has closed $4M in the first tranche of its Series C financing.
Apama Medical, Inc., a privately held medical device company committed to improving patient outcomes by developing a novel catheter ablation system for the underpenetrated atrial fibrillation (AF) market, today announced it has closed $13M in a Series C financing from existing investors.
One interesting and characteristic example is Amr Salahieh, currently founder, president and CEO of Shifamed. He received his bachelor’s degrees at Case Western Reserve in Cleveland in both biomedical and electronical engineering. From there he got a job and worked in increasingly senior roles at a few cardiovascular device companies, including Advanced Cardiovascular Systems and Cardiothoracic Systems.
Abbott Announced today that is has acquired Kalila Medical, Inc, a private medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation.
Amr Salahieh is a seasoned medical device entrepreneur with more than 20 years of experience. He is the founder, president and CEO of Shifamed, LLC, a Campbell, California, based medical technology incubator focused on developing new medical products from concept to commercial release.
Fifteen years ago, medtech incubators were booming, but the model had fallen out of favor by the mid 2000s, partly because incubators ran into funding problems. Now new incubator Shifamed believes it has found a solution to the financing dilemma.
Shifamed LLC, a medical technology incubator, today announced that it will formally introduce its patented coaxial steerable catheter technology in 4 Fr size at MD&M East on June 10-12, 2014 at the Jacob K. Javits Convention Center,New York City, NY. “As we see the field move toward smaller systems, we are proud that our innovative design allowed us to develop our coaxial steerable technology in the small 4 Fr size,” commented Amr Salahieh, Founder and Chairman of Shifamed. “Our proprietary design offers the opportunity for reduced overall wall thickness, providing a larger inner diameter for an equal outer diameter. Now, innovators can be in the forefront of designing and developing the smallest catheters available.”
Shifamed LLC, a medical technology incubator, today announced the allowances of claims in key additional patents for its steerable catheter technology that enables tip deflection without the limitations of traditional pullwire technology. Pull-wire based deflection systems have inherent restrictions including poor torque response and ‘whipping’ of the tip during rotation. The patented technology includes a […]
Shifamed LLC, a medical technology incubator, announced today that Apama Medical, Inc., one of its privately held portfolio companies, has raised $3.2M in Series A-1 financing. Broadview Ventures led the financing round and converted its initial investment to Series A-1 equity. Broadview is a Boston-based investment firm focused on accelerating the development of promising technology in cardiovascular and neurovascular disease through targeted investments in early stage ventures.
Apama Medical, a privately held medical device company focused on the development of next-generation atrial fibrillation technologies, today announced the issuance of U.S. Patent No. 8295902 by the US Patent and Trademark Office (USPTO), titled “Low Profile Electrodes”.
Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced the issuance of U.S. Patent No. 8,323,241 by the US Patent and Trademark Office (USPTO), titled “Steerable Medical Delivery Devices and Methods of Use”.